Associations of cereal grains intake with cardiovascular disease and mortality across 21 countries in Prospective Urban and Rural Epidemiology study: prospective cohort study

dc.authorid0000-0002-4006-1049
dc.authorid0000-0001-5038-6210
dc.authorid0000-0003-4776-5601
dc.authorid0000-0001-8166-1182
dc.authorid0000-0003-4863-9666
dc.authorid0000-0003-2149-847X
dc.authorid0000-0003-3595-9759
dc.contributor.authorSwaminathan, Sumathi
dc.contributor.authorDehghan, Mahshid
dc.contributor.authorRaj, John Michael
dc.contributor.authorThomas, Tinku
dc.contributor.authorRangarajan, Sumathy
dc.contributor.authorJenkins, David
dc.contributor.authorMony, Prem
dc.date.accessioned2025-05-10T19:40:38Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractOBJECTIVE To evaluate the association between intakes of refined grains, whole grains, and white rice with cardiovascular disease, total mortality, blood lipids, and blood pressure in the Prospective Urban and Rural Epidemiology (PURE) study. DESIGN Prospective cohort study. SETTING PURE study in 21 countries. PARTICIPANTS 148 858 participants with median follow-up of 9.5 years. EXPOSURES Country specific validated food frequency questionnaires were used to assess intakes of refined grains, whole grains, and white rice. MAIN OUTCOME MEASURE Composite of mortality or major cardiovascular events (defined as death from cardiovascular causes, nonfatal myocardial infarction, stroke, or heart failure). Hazard ratios were estimated for associations of grain intakes with mortality, major cardiovascular events, and their composite by using multivariable Cox frailty models with random intercepts to account for clustering by centre. RESULTS Analyses were based on 137 130 participants after exclusion of those with baseline cardiovascular disease. During follow-up, 9.2% (n=12 668) of these participants had a composite outcome event. The highest category of intake of refined grains (>= 350 g/ day or about 7 servings/day) was associated with higher risk of total mortality (hazard ratio 1.27, 95% confidence interval 1.11 to 1.46; P for trend=0.004), major cardiovascular disease events (1.33, 1.16 to 1.52; P for trend<0.001), and their composite (1.28, 1.15 to 1.42; P for trend<0.001) compared with the lowest category of intake (<50 g/day). Higher intakes of refined grains were associated with higher systolic blood pressure. No significant associations were found between intakes of whole grains or white rice and health outcomes. CONCLUSION High intake of refined grains was associated with higher risk of mortality and major cardiovascular disease events. Globally, lower consumption of refined grains should be considered.
dc.description.sponsorshipHeart and Stroke Foundation of Ontario; Population Health Research Institute; Hamilton Health Sciences Research Institute (HHSRI); Canadian Institutes of Health Research; Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit; Ontario Ministry of Health and Long term Care; AstraZeneca (Canada); Sanofi-Aventis (France and Canada); Boehringer Ingelheim (Germany and Canada); Servier; GlaxoSmithKline; Novartis; King Pharma; Farmers of Canada; National Dairy Council (US); Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de La Frontera [DI13-PE11]; Colombia: Colciencias [6566-04-18062, 6517-777-58228]; Malaysia: Ministry of Science, Technology and Innovation of Malaysia [100-IRDC/BIOTEK 16/6/21 [13/2007], 07-05-IFN-BPH 010]; Ministry of Higher Education of Malaysia [600-RMI/LRGS/5/3 [2/2011]]; Universiti Kebangsaan Malaysia [UKM-Hejim-Komuniti-15-2010]; Poland: Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]; Swedish state; Swedish Heart and Lung Foundation; Swedish Research Council; Swedish Council for Health, Working Life and Welfare; King Gustaf V's and Queen Victoria Freemason's Foundation; AFA Insurance
dc.description.sponsorshipSY is supported by the Marion W Burke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator initiated study that is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute (HHSRI), the Canadian Institutes of Health Research, and the Heart and Stroke Foundation of Ontario, with support from the Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long term Care, and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithKline) and additional contributions from Novartis and King Pharma and from various national or local organisations in participating countries. These include Argentina: Fundacion ECLA (Estudios Clinicos Latino America); Bangladesh: Independent University, Bangladesh, and Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: unrestricted grant from Dairy Farmers of Canada and the National Dairy Council (US), Public Health Agency of Canada, and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de La Frontera (DI13-PE11); China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development; Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228); India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant number: 100-IRDC/BIOTEK 16/6/21 [13/2007], and 07-05-IFN-BPH 010), Ministry of Higher Education of Malaysia (grant number: 600-RMI/LRGS/5/3 [2/2011]), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, International Development Research Centre, Canada; Philippines: Philippine Council for Health Research and Development; Poland: Polish Ministry of Science and Higher Education (grant number: 290/W-PURE/2008/0), Wroclaw Medical University; Saudi Arabia: Saudi Heart Association, Saudi Gastroenterology Association, Dr Mohammad Alfagih Hospital, the Deanship of Scientific Research at King Saud University, Riyadh, (research group number: RG-1436-013); South Africa: North-West University, Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, South Africa Sugar Association, Faculty of Community and Health Sciences; Sweden: grants from the Swedish state under the agreement concerning research and education of doctors, the Swedish Heart and Lung Foundation, the Swedish Research Council, the Swedish Council for Health, Working Life and Welfare, King Gustaf V's and Queen Victoria Freemason's Foundation, AFA Insurance; Turkey: Metabolic Syndrome Society, AstraZeneca, Sanofi Aventis; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, Dubai Health Authority, Dubai. The external funders and sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; in the preparation, review, or approval of the manuscript; or in the decision to submit the manuscript for publication. Please refer to the supplementary material for a list of PURE project office staff, national coordinators, investigators, and key staff.
dc.identifier.doi10.1136/bmj.m4948
dc.identifier.issn0959-535X
dc.identifier.issn1756-1833
dc.identifier.pmid33536317
dc.identifier.scopus2-s2.0-85100381453
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1136/bmj.m4948
dc.identifier.urihttps://hdl.handle.net/20.500.14730/10059
dc.identifier.volume372
dc.identifier.wosWOS:000686315900001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBmj Publishing Group
dc.relation.ispartofBmj-British Medical Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectCoronary-Heart-Disease
dc.subjectDose-Response Metaanalysis
dc.subjectAll-Cause Mortality
dc.subjectWhole-Grain
dc.subjectFood-Consumption
dc.subjectRice Consumption
dc.subjectCancer-Mortality
dc.subjectRefined-Grain
dc.subjectRisk
dc.subjectFruit
dc.titleAssociations of cereal grains intake with cardiovascular disease and mortality across 21 countries in Prospective Urban and Rural Epidemiology study: prospective cohort study
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
10059.pdf
Boyut:
570.43 KB
Biçim:
Adobe Portable Document Format